-
Abstract Number: 374
The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases: Subgroup with Autoimmune Diseases
-
Abstract Number: 375
Experience with Biologic Agents for the Treatment of Cardiac Sarcoidosis in a U.S. Academic Medical Center
-
Abstract Number: 376
Long-term Outcome and Prognostic Factors of Patients with Interstitial Pneumonia with Autoimmune Features: A Single Center Large-scale Observational Cohort Study
-
Abstract Number: 377
Novel Approach to the Treatment of Cardiac Sarcoidosis with TNF-alpha Inhibition
-
Abstract Number: 378
Systemic and Ocular Sarcoidosis Study of 381 Patients from a Single Universitary Centre in the Last 20 Years
-
Abstract Number: 379
Neurosarcoidosis: An Evaluation Based on the Neurosarcoidosis Consortium Consensus Group
-
Abstract Number: 380
Seasonal Clustering of Acute Sarcoidosis in South-West Germany and Associations with Particulate Matter Air Pollution
-
Abstract Number: 381
Effect of Vitamin D Supplementation on Calcium Levels in Patients with Sarcoidosis: A Retrospective Analysis
-
Abstract Number: 382
Neurofilament Light Chain Levels in Cerebrospinal Fluid and Plasma in Neurosarcoidosis
-
Abstract Number: 383
Retroperitoneal Fibrosis- a Single Center Experience
-
Abstract Number: 384
Prevalence and Predictors of Fibrosis in Rheumatological Patients on Therapy and Risk Factors for Chronic Liver Disease
-
Abstract Number: 385
Distinctive Clinical Features and Biomarkers of Connective Tissue Disease Associated Interstitial Lung Disease
-
Abstract Number: 386
Idiopathic Granulomatous Mastitis: The Role of Rheumatologists in Treating This Rare Cause of Breast Pain
-
Abstract Number: 387
Early Mortality in IgG4-Related Disease
-
Abstract Number: 388
Treating Statin-induced Anti-HMGCR Myopathy with Normal Muscle Strength: A New Window of Opportunity
- « Previous Page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- …
- 198
- Next Page »